Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 24.73% |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -40.88% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -28.55% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 21.66% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -16.07% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | 92.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92.49% |
| Sep 30, 2025 | 26.99% |
| Jun 30, 2025 | -6.59% |
| Mar 31, 2025 | 13.45% |
| Dec 31, 2024 | -12.69% |
| Sep 30, 2024 | -19.42% |
| Jun 30, 2024 | -15.87% |
| Mar 31, 2024 | 13.57% |
| Dec 31, 2023 | -51.59% |
| Sep 30, 2023 | -71.00% |
| Jun 30, 2023 | -52.93% |
| Mar 31, 2023 | 66.70% |
| Dec 31, 2022 | -50.70% |
| Sep 30, 2022 | 33.89% |
| Jun 30, 2022 | -33.22% |
| Mar 31, 2022 | -47.59% |
| Dec 31, 2021 | 182.59% |
| Sep 30, 2021 | 344.22% |
| Jun 30, 2021 | 178.81% |
| Mar 31, 2021 | -63.74% |